Boston Scientific has announced plans to close its Galil Medical site in Yokne'am, Israel, and transfer operations to its facility in Galway, Ireland by 2028. The move will affect around 100 employees, who have been notified and will be offered support and opportunities within the company. Despite the closure, Boston Scientific emphasized its ongoing commitment to Israel, highlighting its continued investment in other medical technology ventures in the country. Galil Medical, known for its innovative cancer treatment devices, has a long history in Israel's medical device sector and was acquired by Boston Scientific in 2019.